Welcome to This Week in Ophthalmology. This week we're covering nine notable papers spanning the management of chronic retinal disease, new insights in cataract and cornea, and innovative approaches to diagnostics and future therapies. Let's dive in.

This week's papers:

1. Real-World Outcomes after Switch to Aflibercept 8 mg in Neovascular AMD: Twelve Months Follow-up on 654 Eyes. — Retina (Philadelphia, Pa.) 2026
2. Disorganization of inner retinal layers and disruption of outer retinal layers as predictors of anti-vascular endothelial growth factor treatment outcomes in diabetic macular edema: A scoping review. — Survey of ophthalmology 2026
3. Pathologic Myopia Globe Shape and Long-Term Prognosis. — JAMA ophthalmology 2026
4. Evidence and Consensus Based Guidelines in Vogt-Koyanagi-Harada Disease. Multimodal imaging in Uveitis (MUV) Taskforce Report 16. — Ophthalmology. Retina 2026
5. Accuracy of 8 modern intraocular lens power calculation formulas in Asian eyes with axial length ≥ 32.00 mm. — American journal of ophthalmology 2026
6. Genetic Prediction of Keratoplasty in Fuchs Endothelial Corneal Dystrophy. — Ophthalmology 2026
7. Cost Analysis of an Outpatient MRI Pathway for Optic Disc Edema: A Time-Driven Activity-Based Costing Approach. — American journal of ophthalmology 2026
8. A Clinically Relevant Threshold of Impaired Contrast Sensitivity Among Older US Adults. — JAMA ophthalmology 2026
9. Coordinated regulation using small-molecule drugs enables controlled therapeutic genome editing and enhanced genomic precision in situ. — Science translational medicine 2026

Listen at AudioScholar